Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Progression of Prostate Cancer”

133 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 133 results

Testing effectiveness (Phase 2)Study completedNCT02326805
What this trial is testing

PROSTVAC (PSA-TRICOM) in Preventing Disease Progression in Patients With Localized Prostate Cancer Undergoing Active Surveillance

Who this might be right for
Stage I Prostate Adenocarcinoma AJCC v7Stage II Prostate Adenocarcinoma AJCC v7
National Cancer Institute (NCI) 154
Not applicableUnknownNCT03988686
What this trial is testing

Testing Radical Prostatectomy in Chinese Men With Prostate Cancer and oligoMetastases to the Bone

Who this might be right for
Prostate Cancer Metastatic
Fudan University 120
Testing effectiveness (Phase 2)Looking for participantsNCT04503265
What this trial is testing

A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies

Who this might be right for
Advanced Malignant NeoplasmBreast CancerOvarian Cancer+3 more
AtlasMedx, Incorporated 122
Not applicableLooking for participantsNCT06046131
What this trial is testing

Clinical, Genetic and Environmental Determinants of Prostate Cancer Progression.

Who this might be right for
Prostatic NeoplasmAdenocarcinomaNeoplasm Recurrence+1 more
Centre Hospitalier Universitaire de la Guadeloupe 3,000
Testing effectiveness (Phase 2)Looking for participantsNCT05751434
What this trial is testing

A Study on the Effects of Exercise Therapy on Signs of Prostate Cancer

Who this might be right for
Prostate CancerProstate AdenocarcinomaLocalized Prostate Carcinoma
City of Hope Medical Center 102
Testing effectiveness (Phase 2)Study completedNCT00082134
What this trial is testing

Study of ILX651 in Patients With Hormone-Refractory Prostate Cancer Previously Treated With Docetaxel

Who this might be right for
Hormone-refractory Prostate Cancer
Genzyme, a Sanofi Company 40
Testing effectiveness (Phase 2)Looking for participantsNCT05191680
What this trial is testing

TherApeutics in Early ProState Cancer (TAPS02)

Who this might be right for
Prostate Cancer
Cambridge University Hospitals NHS Foundation Trust 90
Testing effectiveness (Phase 2)Study completedNCT01393730
What this trial is testing

Abiraterone Acetate Combined With Dutasteride for Metastatic Castrate Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Mary-Ellen Taplin, MD 40
Testing effectiveness (Phase 2)Study completedNCT00678054
What this trial is testing

Study of Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) for Patients With Rising Prostate-Specific Antigen (PSA)

Who this might be right for
Prostate Cancer
University of California, San Francisco 30
Not applicableActive Not RecruitingNCT07607431
What this trial is testing

Risk Factors, Incidence, and Progression of Lymphedema Among Men With Prostate Cancer. The AWARE Cohort

Who this might be right for
Prostate CancerLower Limb Lymphedema
Rigshospitalet, Denmark 214
Not applicableLooking for participantsNCT05931419
What this trial is testing

High-Risk prostatE Cancer radiatiOn Versus surgERy

Who this might be right for
Prostate CancerProstate Adenocarcinoma
Comprehensive Cancer Centre The Netherlands 837
Testing effectiveness (Phase 2)UnknownNCT00045123
What this trial is testing

R-Flurbiprofen in Treating Patients With Localized Prostate Cancer at Risk of Recurrence

Who this might be right for
Prostate Cancer
Myrexis Inc.
Not applicableLooking for participantsNCT05918263
What this trial is testing

Exercise for Tumor Suppressive Impact in Men With Prostate Cancer at High-Risk of Progression on Active Surveillance: The REMOVE Trial

Who this might be right for
Prostate CancerProstatic Neoplasms
Fred Hutchinson Cancer Center 68
Testing effectiveness (Phase 2)Study completedNCT02137746
What this trial is testing

Study to Allow for Second Treatment Cycle of DCVAC in Patients With Localized Prostate Cancer

Who this might be right for
Prostate Cancer
SOTIO a.s. 24
Testing effectiveness (Phase 2)Study completedNCT01220973
What this trial is testing

Atorvastatin Calcium and Celecoxib in Treating Patients With Rising PSA Levels After Local Therapy for Prostate Cancer

Who this might be right for
Prostate Cancer
Rutgers, The State University of New Jersey 27
Testing effectiveness (Phase 2)Looking for participantsNCT06582628
What this trial is testing

Talazoparib Plus Enzalutamide After Progression to Abiraterone in Metastatic Prostate Cancer: (TEAM PC)

Who this might be right for
Metastatic Prostate Cancer
Fundacion Oncosur 78
Testing effectiveness (Phase 2)Study completedNCT00659438
What this trial is testing

Efficacy and Safety of Zactima™ in Patients With Castration-refractory Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Genzyme, a Sanofi Company 95
Not applicableLooking for participantsNCT07686016
What this trial is testing

Prostate Radiotherapy and Metastasis-Directed Therapy in Synchronous Oligometastatic Prostate Cancer

Who this might be right for
Prostate CancerMetastatic Prostate CancerOligometastatic Prostate Cancer+1 more
Affidea Nu-med Center of Oncological DIagnostics and Therapy 700
Large-scale testing (Phase 3)Study completedNCT00027859
What this trial is testing

Hormone Therapy Compared With Combination Chemotherapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Study completedNCT01204710
What this trial is testing

Olaratumab (IMC-3G3) in Prostate Cancer

Who this might be right for
Prostate Cancer
Eli Lilly and Company 123
Next Page